Works matching IS 11750561 AND DT 2021 AND VI 22 AND IP 5


Results: 14
    1
    2
    3
    4
    5

    Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program.

    Published in:
    American Journal of Clinical Dermatology, 2021, v. 22, n. 5, p. 693, doi. 10.1007/s40257-021-00618-3
    By:
    • Simpson, Eric L.;
    • Silverberg, Jonathan I.;
    • Nosbaum, Audrey;
    • Winthrop, Kevin L.;
    • Guttman-Yassky, Emma;
    • Hoffmeister, Karin M.;
    • Egeberg, Alexander;
    • Valdez, Hernan;
    • Zhang, Min;
    • Farooqui, Saleem A.;
    • Romero, William;
    • Thorpe, Andrew J.;
    • Rojo, Ricardo;
    • Johnson, Susan
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14